Literature DB >> 21354422

Elucidating substrate and inhibitor binding sites on the surface of GSK-3β and the refinement of a competitive inhibitor.

Avital Licht-Murava1, Batya Plotkin, Miriam Eisenstein, Hagit Eldar-Finkelman.   

Abstract

A molecular understanding of substrate recognition of protein kinases provides an important basis for the development of substrate competitive inhibitors. Here, we explored substrate recognition and competitive inhibition of glycogen synthase kinase (GSK)-3β using molecular and computational tools. In previous work, we described Gln89 and Asn95 within GSK-3β as important substrates binding sites. Here, we show that the cavity bordered by loop 89-QDKRFKN-95, located in the vicinity of the GSK-3β catalytic core, is a promiscuous substrate binding subsite. Mutations within this segment highlighted Phe93 as an additional essential contact residue for substrates' recognition. However, unlike Gln89 and Asn95, Phe93 was also important for the binding of our previously described substrate competitive inhibitor, L803 [KEAPPAPPQS(p)P], and its cell-permeable variant L803-mts. The effects of the substitution of charged or polar residues within L803 further suggested that binding to GSK-3β is governed by hydrophobic interactions. Our computational model of GSK-3β bound to L803 was in agreement with the experimental data. It revealed L803 binding with a hydrophobic surface patch and identified interactions between Pro8 (L803) and Phe93 (GSK-3β). Computational modeling of new L803 variants predicted that inhibition would be strengthened by adding contacts with Phe93 or by increasing the hydrophobic content of the peptide. Indeed, the newly designed L803 variants showed improved inhibition. Our study identified different and overlapping elements in GSK-3β substrate and inhibitor recognition and provides a novel example for model-based rational design of substrate competitive inhibitors for GSK-3.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354422     DOI: 10.1016/j.jmb.2011.02.036

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

Review 1.  Inhibitory kappa B Kinases as targets for pharmacological regulation.

Authors:  Carly Gamble; Kathryn McIntosh; Rebecca Scott; Ka Ho Ho; Robin Plevin; Andrew Paul
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.

Authors:  Akhil Kumar; Gaurava Srivastava; Swati Srivastava; Seema Verma; Arvind S Negi; Ashok Sharma
Journal:  J Mol Model       Date:  2017-07-24       Impact factor: 1.810

3.  GSK-3β Inhibition in Birds Affects Social Behavior and Increases Motor Activity.

Authors:  Stan Moaraf; Ido Rippin; Joseph Terkel; Hagit Eldar-Finkelman; Anat Barnea
Journal:  Front Physiol       Date:  2022-04-28       Impact factor: 4.755

4.  Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.

Authors:  Eléonore Beurel; Oksana Kaidanovich-Beilin; Wen-I Yeh; Ling Song; Valle Palomo; Suzanne M Michalek; James R Woodgett; Laurie E Harrington; Hagit Eldar-Finkelman; Ana Martinez; Richard S Jope
Journal:  J Immunol       Date:  2013-04-19       Impact factor: 5.422

Review 5.  Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.

Authors:  Margaret K King; Marta Pardo; Yuyan Cheng; Kimberlee Downey; Richard S Jope; Eléonore Beurel
Journal:  Pharmacol Ther       Date:  2013-07-31       Impact factor: 12.310

6.  GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS.

Authors:  Hagit Eldar-Finkelman; Ana Martinez
Journal:  Front Mol Neurosci       Date:  2011-10-31       Impact factor: 5.639

7.  Bioactivities and Mode of Actions of Dibutyl Phthalates and Nocardamine from Streptomyces sp. H11809.

Authors:  Fauze Mahmud; Ngit Shin Lai; Siew Eng How; Jualang Azlan Gansau; Khairul Mohd Fadzli Mustaffa; Chiuan Herng Leow; Hasnah Osman; Hasidah Mohd Sidek; Noor Embi; Ping-Chin Lee
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

8.  Positioning of an unprecedented spiro[5.5]undeca ring system into kinase inhibitor space.

Authors:  Arramshetti Venkanna; Lalita Subedi; Mahesh K Teli; Prema Dhorma Lama; Bhargav Gupta Nangunuri; Sang-Yoon Lee; Sun Yeou Kim; Mi-Hyun Kim
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

Review 9.  Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration.

Authors:  Ido Rippin; Hagit Eldar-Finkelman
Journal:  Cells       Date:  2021-01-29       Impact factor: 6.600

10.  Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site.

Authors:  Ido Rippin; Netaly Khazanov; Tania Kudinov; Eva Berent; Sara Melisa Arciniegas Ruiz; Daniele Marciano; Laura Levy; Arie Gruzman; Hanoch Senderowitz; Hagit Eldar-Finkelman
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.